AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

NCT05850234 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
182
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca